The enrichment analysis of KEGG pathway suggested that compounds had therapeutic effect on NSCLC by regulating pathways, including PI3K-Akt signaling pathway and erbB signaling pathway (Figure 1). Here, EGFR is linked to non-small cell lung carcinoma.